Hematuria pathophysiology: Difference between revisions
Jump to navigation
Jump to search
Adnan Ezici (talk | contribs) No edit summary |
Adnan Ezici (talk | contribs) No edit summary |
||
| Line 41: | Line 41: | ||
*In the pathogenesis of fibrillary glomerulonephritis: | *In the pathogenesis of fibrillary glomerulonephritis: | ||
**10-30 nm fibrils | **10-30 nm fibrils | ||
*In the pathogenesis of fabry’s disease: | *In the pathogenesis of [[fabry’s disease]]: | ||
**lysosomal storage | **lysosomal storage | ||
*In the pathogenesis of immunotactoid glomerulonephritis: | *In the pathogenesis of immunotactoid glomerulonephritis: | ||
| Line 60: | Line 60: | ||
==Microscopic Pathology== | ==Microscopic Pathology== | ||
Microscopic pathology might differ depending on the underlying etiology of hematuria. | |||
*On microscopic histopathological analysis, | |||
**Diffuse thinning of the glomerular basement membrane (GBM) is characteristic finding of '''[[thin basal membrane disease]]'''<ref name="pmid15880325">{{cite journal |vauthors=Foster K, Markowitz GS, D'Agati VD |title=Pathology of thin basement membrane nephropathy |journal=Semin Nephrol |volume=25 |issue=3 |pages=149–58 |date=May 2005 |pmid=15880325 |doi=10.1016/j.semnephrol.2005.01.006 |url=}}</ref> | |||
**Lobular appearance with massive fibronectin deposits and the absence of immunoglobulin/complement deposition are characteristic findings of '''fibronectin nephropathy'''<ref name="pmid29055354">{{cite journal |vauthors=Lusco MA, Chen YP, Cheng H, Dong HR, Najafian B, Alpers CE, Fogo AB |title=AJKD Atlas of Renal Pathology: Fibronectin Glomerulopathy |journal=Am J Kidney Dis |volume=70 |issue=5 |pages=e21–e22 |date=November 2017 |pmid=29055354 |doi=10.1053/j.ajkd.2017.09.001 |url=}}</ref> | |||
**Randomly aligned fibrillar deposits that measure 12-24 nm is characteristic finding of '''fibrillary nephropathy'''<ref name="KlomjitAlexander2020">{{cite journal|last1=Klomjit|first1=Nattawat|last2=Alexander|first2=Mariam Priya|last3=Zand|first3=Ladan|title=Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9)|journal=Kidney360|volume=1|issue=9|year=2020|pages=1002–1013|issn=2641-7650|doi=10.34067/KID.0002532020}}</ref><ref name="pmid31317113">{{cite journal |vauthors=Rosenstock JL, Markowitz GS |title=Fibrillary Glomerulonephritis: An Update |journal=Kidney Int Rep |volume=4 |issue=7 |pages=917–922 |date=July 2019 |pmid=31317113 |pmc=6611949 |doi=10.1016/j.ekir.2019.04.013 |url=}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 22:43, 19 July 2021
|
Hematuria Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hematuria pathophysiology On the Web |
|
American Roentgen Ray Society Images of Hematuria pathophysiology |
|
Risk calculators and risk factors for Hematuria pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
Pathophysiology
Pathogenesis
It is understood that glomerular hematuria is caused by either the dysfunction or damage of the glomerular filtration barrier(GFB).[1]
- Major components of GFB include:
- Endothelial surface layer (composed of glycosaminoglycans)
- Endothelial cells
- Glomerular basement membrane (GBM)
- Slit diaphragms
- Subpodocyte space
The pathophsiologic mechanism of glomerular hematuria might be further classified into 6 subtype depends on the primary and histopathologic localization.[1]
- Injuries of the glomerular endothelial cell and surface layer
- Primary and secondary GBM disorders
- Diseases that can cause mesangial deposition
- Diseases that can cause subendothelial and subepithelial deposition
- Podocyte-associated disorders
- Miscellaneous
Genetics
Molecular defects involved in the pathogenesis of glomerular hematuria include:[1]
Diseases with structural GBM damage
- In the pathogenesis of alport syndrome:
- COL4A5 (X linked)
- COL4A3/COL4A4 (autosomal recessive)
- In the pathogenesis of thin basement membrane disease:
- COL4A3/COL4A4
- In the pathogenesis of hereditary angiopathy, nephropathy, aneurysms, and muscle cramps syndrome:
- COL4A1
Diseases with structural podocyte damage
- In the pathogenesis of MYH9-related disorder:
- Non muscle myosin IIA heavy chain
Storage disorders
- In the pathogenesis of fibronectin glomerulonephritis:
- Fibronectin
- In the pathogenesis of fibrillary glomerulonephritis:
- 10-30 nm fibrils
- In the pathogenesis of fabry’s disease:
- lysosomal storage
- In the pathogenesis of immunotactoid glomerulonephritis:
- Fibrils that are > 30 nm
Autoimmune disorders
- In the pathogenesis of ANCA (antineutrophil cytoplasmic antibodies):
- Antibodies against endothelium
- In the pathogenesis of anti-GBM:
- Antibodies against COL4
Complement mediated disorders
- In the pathogenesis of C3 glomerulopathy:
- Alternative pathway
Infectious (endocapillary) diseases
- In the pathogenesis of IgA nephritis:
- Galactose-deficient IgA1
Gross Pathology
Microscopic Pathology
Microscopic pathology might differ depending on the underlying etiology of hematuria.
- On microscopic histopathological analysis,
- Diffuse thinning of the glomerular basement membrane (GBM) is characteristic finding of thin basal membrane disease[2]
- Lobular appearance with massive fibronectin deposits and the absence of immunoglobulin/complement deposition are characteristic findings of fibronectin nephropathy[3]
- Randomly aligned fibrillar deposits that measure 12-24 nm is characteristic finding of fibrillary nephropathy[4][5]
References
- ↑ 1.0 1.1 1.2 Yuste C, Gutierrez E, Sevillano AM, Rubio-Navarro A, Amaro-Villalobos JM, Ortiz A, Egido J, Praga M, Moreno JA (May 2015). "Pathogenesis of glomerular haematuria". World J Nephrol. 4 (2): 185–95. doi:10.5527/wjn.v4.i2.185. PMC 4419128. PMID 25949932.
- ↑ Foster K, Markowitz GS, D'Agati VD (May 2005). "Pathology of thin basement membrane nephropathy". Semin Nephrol. 25 (3): 149–58. doi:10.1016/j.semnephrol.2005.01.006. PMID 15880325.
- ↑ Lusco MA, Chen YP, Cheng H, Dong HR, Najafian B, Alpers CE, Fogo AB (November 2017). "AJKD Atlas of Renal Pathology: Fibronectin Glomerulopathy". Am J Kidney Dis. 70 (5): e21–e22. doi:10.1053/j.ajkd.2017.09.001. PMID 29055354.
- ↑ Klomjit, Nattawat; Alexander, Mariam Priya; Zand, Ladan (2020). "Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9)". Kidney360. 1 (9): 1002–1013. doi:10.34067/KID.0002532020. ISSN 2641-7650.
- ↑ Rosenstock JL, Markowitz GS (July 2019). "Fibrillary Glomerulonephritis: An Update". Kidney Int Rep. 4 (7): 917–922. doi:10.1016/j.ekir.2019.04.013. PMC 6611949 Check
|pmc=value (help). PMID 31317113.